文献速递肾癌与肾肿瘤

质量差异对接受肾细胞癌手术患者的影响:一项美国国家癌症数据库研究

The Impact of Quality Variations on Patients Undergoing Surgery for Renal Cell Carcinoma: A National Cancer Database Study.
PubMed 文献 · Eur Urol · 2017-05-13

该研究基于美国国家癌症数据库2004至2014年肾细胞癌手术患者数据,对超过1100家医院进行病例组合调整后的质量基准评价,并构建肾癌质量评分(RC-QS)。结果显示各质量指标中10%至31%的医院被判定为提供较差照护,RC-QS较高的医院转诊量更大、学术属性更强,且与更低的30天、90天及总死亡率独立相关。

要点

  • 超过1100家医院被纳入质量基准评价,各质量指标中10%至31%的医院被判定为提供较差照护。
  • RC-QS较低的医院转诊量较小且学术属性较弱,与RC-QS较高的医院相比差异有统计学意义(p<0.001)。
  • RC-QS每单位升高与更低的30天死亡率(调整比值比0.92,95%CI 0.90-0.95)、90天死亡率(比值比0.94,95%CI 0.91-0.96)及总死亡率(风险比0.97,95%CI 0.96-0.98)独立相关。

核心结论

  • 肾细胞癌手术质量在美国医院层面存在广泛差异,RC-QS可捕捉这一差异。
  • 较高的RC-QS与更好的患者结局独立相关,包括死亡率获益。
  • RC-QS可作为肾细胞癌质量基准工具,为医院和政策制定者提供审计级反馈以促进质量改进。

研究设计与样本

  • 研究为回顾性分析,数据来自美国国家癌症数据库,纳入2004至2014年在美国和波多黎各接受手术的肾细胞癌患者。
  • 采用间接标准化方法和多变量回归模型进行病例组合调整后的医院基准评价。
  • 超过1100家医院被纳入质量基准评价,并据此构建肾癌质量评分(RC-QS)复合质量指标。

主要发现

  • 各质量指标中10%至31%的医院被判定为提供较差照护。
  • RC-QS较低的医院与RC-QS较高的医院相比,转诊量较小且学术属性较弱(p<0.001)。
  • RC-QS每单位升高与更低的30天死亡率独立相关(调整比值比0.92,95%CI 0.90-0.95)。
  • RC-QS每单位升高与更低的90天死亡率独立相关(比值比0.94,95%CI 0.91-0.96)。
  • RC-QS每单位升高与更低的总死亡率独立相关(风险比0.97,95%CI 0.96-0.98)。

关键数值与推荐

  • 医院层面照护质量依据疾病特异性过程和结局质量指标进行评估。
  • 采用间接标准化方法和多变量回归模型进行病例组合调整后的医院基准评价。
  • 复合质量指标RC-QS由上述质量指标衍生而来。

临床怎么用

  • RC-QS可作为肾细胞癌质量的基准工具,为医院和政策制定者提供审计级反馈以促进质量改进。
  • 研究数据可为医院和政策制定者的质量改进举措提供信息。

局限性

  • 数据为回顾性数据。
  • 尚不清楚RC-QS的改善是否能改善结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite efforts to define metrics assessing hospital-level quality for renal cell carcinoma (RCC) surgical care there remains a paucity of real-world data validating their ability to benchmark performance. Consequently, whether poor performance on hospital-level quality indicators is associated with inferior patient outcomes remains unknown. OBJECTIVES: To determine hospital-level variations in RCC surgical quality after adjusting for differences in patient- and tumor-specific factors. Further, to determine associations between hospital-level quality performance and surgical volume, academic affiliation, and patient mortality. DESIGN, SETTING, AND PARTICIPANTS: RCC patients undergoing surgery in the USA and Puerto Rico (2004-2014) were identified from the National Cancer Database. OUTCOME MEASURES AND STATISTICAL ANALYSIS: Hospital-level quality of care was assessed according to disease-specific process and outcome quality indicators. Case-mix adjusted hospital benchmarking was performed using indirect standardization methodology and multivariable regression models. A composite measure of quality, the Renal Cancer Quality Score (RC-QS), was subsequently derived and associations between RC-QS and surgical volume, academic affiliation, and patient mortality were determined. RESULTS AND LIMITATIONS: Over 1100 hospitals were benchmarked for quality, with 10-31% identified as providing poor care for a given quality indicator. Lower RC-QS hospitals had smaller referral volumes and were less academic compared with higher RC-QS hospitals (p<0.001). Higher RC-QS was independently associated with lower 30-d, 90-d, and overall mortality (adjusted odds ratio [confidence interval]: 0.92 [0.90-0.95], odds ratio: 0.94 [0.91-0.96], hazard ratio: 0.97 [0.96-0.98] per unit increase, respectively). These data are retrospective and it is unknown whether improvement in the RC-QS improves outcomes. CONCLUSIONS: Widespread hospital-level variations in RCC surgical quality exist, as captured by the RC-QS. Superior quality is associated with improved patient outcomes, including mortality benefit. The RC-QS serves as a benchmarking tool for RCC quality that can provide audit level feedback to hospitals and policymakers for quality improvement. PATIENT SUMMARY: We benchmarked hospital performance across quality indicators for kidney cancer surgical care. Overall, large variations in quality exist, with high volume academic hospitals demonstrating superior performance and improved patient survival. These data can inform hospitals and policymakers for quality improvement initiatives.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Lawson KA, Saarela O, Abouassaly R, et al. The Impact of Quality Variations on Patients Undergoing Surgery for Renal Cell Carcinoma: A National Cancer Database Study. Eur Urol. 2017. PMID: 28511884. doi:10.1016/j.eururo.2017.04.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。